uclh members meet arthritis
play

UCLH Members Meet: Arthritis Dr Jessica Manson June 2016 Structure of talk Brief introduction to Rheumatology 1. Department at UCLH What kind of patients do we see? What is arthritis? 2. Definitions Cases Role of the

0 downloads 5 Views 647 KB Size Report
  1. UCLH Members Meet: Arthritis Dr Jessica Manson June 2016

  2. Structure of talk Brief introduction to Rheumatology 1. Department at UCLH  What kind of patients do we see?  What is arthritis? 2. Definitions  Cases  Role of the CNS 3. Research in our department 4.

  3. Rheumatology team at UCLH  14 consultants  4 CNS (Sam Moore, lead nurse)  Infusion clinic staff  3 full time registrars  3+ research registrars  F1 and CMT (50%)  Research strong department

  4. Which patients do we see?  Referral from GPs and from other hospitals  50-60 Clinics a week  4300 new appointments and 16000 follow-ups per year  In patients  Very few beds  Day case unit  Infusions  Urgent reviews 4

  5. Rheumatology: what we do Subtotals, 3 month data 1600 Diagnosis % 1400 1200 IA 40 1000 Pain/OA/ 21 HM 800 AIRD 17 600 400 Bone 12 200 Misc 10 0 Total inflamm Total AIRD Total Total bone Total misc arthritis Pain/OA/HM 5

  6. What is arthritis? 6

  7. Arthritis Inflammatory Autoimmune Rheumatoid Spondylo- Crystal rheumatic arthritis arthropathy arthropathy disease Non- inflammatory Osteoarthritis Tendonopathy

  8. 3 cases…  All presented with joint pain  Different diseases  Different management 8

  9. Osteoarthritis case  67 year old woman  Known obesity, type II diabetes  Localized pain and restricted ROM  Base of thumb  Lumps of fingers  Right shoulder  Right knee  Pain worse on use and end of the day  Stiff fingers in the morning 9

  10. Osteoarthritis: patterns of disease http://www.arthritisresearchuk.org 10

  11. Osteoarthritis of the hand 11

  12. 12

  13. Osteoarthritis: what the patient can do  Pain killers  Work a bit  Keep active  Walking >6000 steps a day predicts good outcome over 2 years in knee OA  Lose weight  Obesity is a risk factor for OA, even in non-weight bearing joints 13

  14. Osteoarthritis: what doctors can do Dispelling myths  It is not wear and tear  It is not an inevitable process as we get older  Early changes do not inevitably proceed Treatments  Phsyiotherapy  Analgesia  Surgery Research  We need a disease modifying drug 14

  15. Rheumatoid arthritis case  21 computer programmer  4 month history of pain in multiple joints  Mainly hands and knees  Early morning stiffness 4 hours  Fatigue

  16. On examination

  17. Investigations: blood tests  High inflammatory markers  But not always  Antibodies in blood  But not always 17

  18. What to do when it is not clear Clinical assessment Diagnosis clear Diagnosis unclear Inflammatory arthritis No evidence of MSK US inflammatory arthritis Start treatment Discharge

  19. 1 Normal scan 3 Erosion 2 Synovitis 4 Osteophyte

  20. Rheumatoid arthritis: management  Treat aggressively and early  Steroids  Disease modifying drugs  Methrexate, sulphasalzine, hydroxychloroquine  Biologics  The role of NICE

  21. SLE case  30 year woman  3/12 history joint pain, small joints of hands  Incapacitating fatigue  Rash on face on exposure to sunlight  Rash on hands

  22. What is lupus? 1 Malar rash 2 Discoid rash 3 Photosensitivity 4 Oral ulcers 5 Non-erosive arthritis 6 Pleuritis/pericarditis 7 Renal disorder 8 Neurological disorder 9 Haematological order 10 Immunologic disorder 11 Positive ANA

  23. SLE: management and outcome  Long term treatment with immunosuppression  ?lifelong  Careful monitoring especially at high risk times eg pregnancy In this case:  Stable, chronic disease  Working full time  2 children

  24. SLE: prognosis  Hugely improved in last 50 years but…  10 year survival in UK about 95%  Which means 5% don’t survive 10 years 25

  25. Summary Arthritis is not a diagnosis 1. Most of our work is done in out-patients looking after 2. inflammatory pathology We have a desperate need for a drug to treat 3. osteoarthritis The last 10-15 years has seen a transformation in 4. the way rheumatoid arthritis is managed Patients often get to know us very well, and vice- 5. versa!

  26. Thank-you. Any questions?

Recommend Documents


uclh members meet
UCLH Members Meet Pituitary disorders

UCLH Members Meet Pituitary disorders UCLH Department of Diabetes &

uclh
UCLH CANCER STRATEGY July 2015 Geoff

UCLH CANCER STRATEGY July 2015 Geoff Bellingan Medical Director, Surgery

uclh council of governor
UCLH Council of Governor Election

UCLH Council of Governor Election Special MembersMeet 6 May 2015 Ros Waring

rheumatoid arthritis
Rheumatoid Arthritis Advances in

Rheumatoid Arthritis Advances in Rheumatoid Arthritis Systemic disease

pain management uclh members meeting
Pain Management UCLH Members meeting

Pain Management UCLH Members meeting October 2014 Ali Mofeez Consultant in

this is uclh
This is UCLH Introduction for

This is UCLH Introduction for prospective governors Liz Rose, Membership

introduction rheumatoid arthritis to what is rheumatoid
Introduction Rheumatoid Arthritis to

Introduction Rheumatoid Arthritis to What is Rheumatoid Arthritis? It is a

objectives objectives
Objectives Objectives Rheumatoid

Objectives Objectives Rheumatoid Arthritis Rheumatoid Arthritis Recognize

race overview
RACE: Overview Authors | Affiliations

RACE: Overview Authors | Affiliations Arthritis Research UK Rheumatoid

arthritis
Arthritis What is it and what causes

Arthritis What is it and what causes it? Matt Brown Professor and Director

navicular syndrome heel pain navicular syndrome heel pain
Navicular Syndrome/Heel Pain Navicular

Navicular Syndrome/Heel Pain Navicular Syndrome/Heel Pain Clinical signs:

placebos in pain and sadness
Placebos in Pain and Sadness Tobias

Mechanisms of Open-Label Placebos in Pain and Sadness Tobias Kube, PhD

panbc annual education day
PANBC Annual Education Day REGIONAL

PANBC Annual Education Day REGIONAL ANESTHESIA CLINICAL UPDATE AND REVIEW

10 1 2018 1
10/1/2018 1 10/1/2018 The Bloom of

10/1/2018 1 10/1/2018 The Bloom of Hemp: CBD Oils in the Community Pharmacy

it s time to get organized anesthesia hygiene
Its Time to Get Organized Anesthesia

Its Time to Get Organized Anesthesia Hygiene www.anesthesiahygiene.com

slowing t g the i e inpatien ent fasting e g epidem emic
Slowing t g the I e Inpatien ent

Slowing t g the I e Inpatien ent Fasting E g Epidem emic Andrew Higdon,

2 signaling
2+ Signaling mediated Ca 2+ cADP-

2+ Signaling mediated Ca 2+ cADP- -Ribose Ribose- -mediated Ca Signaling

on the cusp
ON THE CUSP: A New Option for

PS124 ON THE CUSP: A New Option for Addressing Administrative Burden Aubrey

temporary cardiac pacing
Temporary Cardiac Pacing 1 Objectives

Temporary Cardiac Pacing 1 Objectives Outline various types of temporary

8 15 19
8/15/19 Karolynn Echols, MD

8/15/19 Karolynn Echols, MD Consultant Coloplast, Allergan Post-Operative

trends nds in m n mul ultipl ple n nalox oxone one adm
Trends nds in M n Mul ultipl ple N

Trends nds in M n Mul ultipl ple N Nalox oxone one Adm dmini

adressing problematic opioid use in oecd countries
ADRESSING PROBLEMATIC OPIOID USE IN

ADRESSING PROBLEMATIC OPIOID USE IN OECD COUNTRIES Stefano Scarpetta